当前位置: 首页 > 期刊 > 《中国美容医学》 > 2008年第8期
编号:11669830
建立嵌合体诱导移植免疫耐受的研究进展(4)
http://www.100md.com 2008年8月1日 《中国美容医学》 2008年第8期
     [16]Karim M,Steger U,Bushell AR,et al.The role of the graft in establishing tolerance[J].Front Biosci,2002, 7:e129-e154.

    [17]Jones TR,Adams AB,Shirasugi NJ,et al.Allogeneic parenchymal and hematopoietic tissues differ in their ability to induce deletion of donor-reactive T cells[J].Am J Transplant,2003,3:1520-1530.

    [18]Zhao Y,Ohdan H,Manilay JO,et al.NK cell tolerance in mixed allogeneic chimeras[J].J Immunol,2003,170:5398-5405.

    [19]Nikolic B,Takeuchi Y,Leykin I,et al.Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity[J].Diabetes,2004,53:376-383.

    [20]Giralt S,Estey E,Albitar M,et al.Engraftment of allogeneic hemato-poietic progenitor cellswith purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy[J].Blood, 1997,89(12):4531-4536.

    [21]Fehr T ......
上一页1 2 3 4

您现在查看是摘要页,全文长 3959 字符